Paper
12 January 1995 Fluorescence detection of MSH-receptors in melanoma as a target of hormone-directed photosensitation in PDT
Susanne Roehrs, Joerg G. Moser, Yoram Salomon
Author Affiliations +
Proceedings Volume 2325, Photodynamic Therapy of Cancer II; (1995) https://doi.org/10.1117/12.199162
Event: International Symposium on Biomedical Optics Europe '94, 1994, Lille, France
Abstract
MSH receptors are one of the possible targets to specifically attack melanoma cells by photodynamically active agents bound to melanotropic hormones. To attack effectively metastatic melanoma the presence of the hormone receptor has to be proven in metastases. Radioactive labeling of melanotropic hormones allows us to check for the presence of intact receptors. We tried to develop a non-radioactive immunological method as a first step to work out therapeutic strategies to attach photodynamically active porphyrins to the surface of melanoma cells.
© (1995) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Susanne Roehrs, Joerg G. Moser, and Yoram Salomon "Fluorescence detection of MSH-receptors in melanoma as a target of hormone-directed photosensitation in PDT", Proc. SPIE 2325, Photodynamic Therapy of Cancer II, (12 January 1995); https://doi.org/10.1117/12.199162
Lens.org Logo
CITATIONS
Cited by 1 scholarly publication.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Melanoma

Receptors

Photodynamic therapy

Cancer

Target detection

Fluorescence spectroscopy

Proteins

Back to Top